Cargando…
Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview
Novel drug delivery systems for controlled-release of opioid agonists as a long time painkillers or opioid antagonists for opium, heroin, and alcohol addiction are under development or in clinical use today. In this article, the field of “new drug delivery systems” is momentarily reviewed from the v...
Autores principales: | Soltani, Hoda, Pardakhty, Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115645/ https://www.ncbi.nlm.nih.gov/pubmed/27882209 |
Ejemplares similares
-
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012) -
Phytoniosome: a Novel Drug Delivery for Myrtle Extract
por: Raeiszadeh, Mahboobeh, et al.
Publicado: (2018) -
Efficient drug delivery of β-estradiol encapsulated in Zn-metal–organic framework nanostructures by microwave-assisted coprecipitation method
por: Ranjbar, Mehdi, et al.
Publicado: (2018) -
Repurposing of a Nucleoside Scaffold from Adenosine
Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018) -
Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
por: Gicquelais, Rachel E., et al.
Publicado: (2020)